Acurx Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-3.4M | $-3.4M | — | $695.8K |
| FY2021 | $-5.0M | $-5.0M | — | $5.2M |
| FY2022 | $-7.5M | $-7.5M | — | $2.9M |
| FY2023 | $-9.8M | $-9.8M | — | $3.2M |
| FY2024 | $-10.4M | $-10.4M | — | $2.6M |